APPLIED GENETIC TECHNOLOGIES (AGTC) Stock Cash Flow
NASDAQ:AGTC - Nasdaq - US03820J1007 - Common Stock - Currency: USD
| TTM (2022-9-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | 2019 (2019-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -70.23M | -68.94M | -57.83M | -45.89M | -2.01M | |||
| Depreciation Amortization | 1.52M | 1.51M | 1.46M | 1.34M | 1.27M | |||
| Change In Working Capital | -2.12M | -3.18M | 3.86M | 2.09M | -25.64M | |||
| Interest Paid | N/A | 1.98M | 1.35M | N/A | N/A | |||
| Taxes Paid | N/A | 0.00 | 396.00K | 400.00K | 0.00 | |||
| Other non cash items | 4.99M | 4.87M | 1.34M | 850.00K | 2.92M | |||
| OPERATING CASH FLOW | -65.85M | -65.75M | -51.17M | -41.62M | -23.46M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.31M | -1.67M | -1.46M | -940.00K | -160.00K | |||
| Other Investing Activity | -395.00K | 1.66M | 39.60M | 9.34M | 19.19M | |||
| INVESTING CASH FLOW | -1.70M | -14.00K | 38.15M | 8.40M | 19.03M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -26.00K | -38.00K | 9.80M | 9.81M | -50.00K | |||
| Stock Issued/Repurchased | 18.64M | 9.34M | 70.06M | 35.20M | 160.00K | |||
| Other Financing Activity | -4.42M | -2.23M | -252.00K | -30.00K | -40.00K | |||
| FINANCING CASH FLOW | 14.20M | 7.08M | 79.61M | 44.98M | 70.00K | |||
| CHANGE IN CASH | -53.35M | -58.69M | 66.59M | 11.76M | -4.36M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -65.85M | -65.75M | -51.17M | -41.62M | -23.46M | |||
| Capital Expenditure | -1.31M | -1.67M | -1.46M | -940.00K | -160.00K | |||
| FREE CASH FLOW | -67.16M | -67.42M | -52.63M | -42.56M | -23.62M | |||
All data in USD